Czechs lead, but EU slow on colorectal cancer screening
This article was originally published in Clinica
EU policymakers have failed to implement the European Council policy on comprehensive screening programmes for colorectal cancer (CRC), and must now take action to prevent unnecessary deaths from this disease.
You may also be interested in...
Becton Dickinson will spend $1.2bn over the next four years to improve its drug-delivery device manufacturing capabilities. See what Eric Borin, president of BD, said about it here.
Pfizer is producing vaccine doses at scale now that it has buttoned down the manufacturing process.
In second letter this year targeting email communications, OPDP says that putting the methotrexate oral solution’s risk information below the signature block does not offer ‘prominence and readability’ comparable to the information on the drug’s effectiveness for the treatment of acute lymphoblastic leukemia that was in the body of the email.